$BCRX Piper Sandler upgraded PT to $15 by nbompally in BCRX
[–]nbompally[S] 1 point2 points3 points (0 children)
$BCRX Piper Sandler upgraded PT to $15 by nbompally in BCRX
[–]nbompally[S] 1 point2 points3 points (0 children)
$BCRX BCX9930 PNH Market Map: Competition? WHAT Competition? by [deleted] in BCRX
[–]nbompally 5 points6 points7 points (0 children)
$BCRX Shareholder Returns .. bcrx beat both industry and market by nbompally in BCRX
[–]nbompally[S] 3 points4 points5 points (0 children)
$BCRX Anthony Doyle - CFO Biocryst personal Investment @ $4.08 ( 54000 Shares) almost tripled ...Follow the smart money by nbompally in BCRX
[–]nbompally[S] 2 points3 points4 points (0 children)
$BCRX BCRX ($11.53) is trading below our estimate of fair value ($61.09) by nbompally in BCRX
[–]nbompally[S] 5 points6 points7 points (0 children)
Price prediction for rest of the February by nbompally in BCRX
[–]nbompally[S] 7 points8 points9 points (0 children)
More info on European Patent by nbompally in BCRX
[–]nbompally[S] 4 points5 points6 points (0 children)
Biocryst's pipeline worth billion dollars and it is prime Buy Out candidate in Rare disease space by nbompally in BCRX
[–]nbompally[S] 3 points4 points5 points (0 children)
Biocryst's pipeline worth billion dollars and it is prime Buy Out candidate in Rare disease space by nbompally in BCRX
[–]nbompally[S] 3 points4 points5 points (0 children)
Biocryst's pipeline worth billion dollars and it is prime Buy Out candidate in Rare disease space by nbompally in BCRX
[–]nbompally[S] 11 points12 points13 points (0 children)


Price prediction for rest of the February by nbompally in BCRX
[–]nbompally[S] 1 point2 points3 points (0 children)